More evidence on additive antipsychotic effect of adjunctive mirtazapine in schizophrenia: an extension phase of a randomized controlled trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

More evidence on additive antipsychotic effect of adjunctive mirtazapine in schizophrenia: an extension phase of a randomized controlled trial

Published:2010-08-19 Issue:6 Volume:25 Page:431-438
ISSN:0885-6222
Container-title:Human Psychopharmacology: Clinical and Experimental
language:en
Short-container-title:Hum. Psychopharmacol. Clin. Exp.

Author:

Terevnikov Viacheslav,Stenberg Jan-Henry,Joffe Marina,Tiihonen Jari,Burkin Mark,Tchoukhine Evgueni,Joffe Grigori

Publisher

Wiley

Subject

Pharmacology (medical),Psychiatry and Mental health,Neurology (clinical),Neurology

Reference41 articles.

1. The effect of mirtazapine add on therapy to risperidone in the treatment of schizophrenia: A double-blind randomized placebo-controlled trial;Abbasi;Schizophr Res,2010

2. A review of the pharmacological and clinical profile of mirtazapine;Anttila;CNS Drug Rev,2001

3. Mirtazapine enhances the effect of haloperidol on apomorphine-induced climbing behaviour in mice and attenuates haloperidol-induced catalepsy in rats;Berendsen;Psychopharmacology,1998

4. Mirtazapine add-on therapy in the treatment of schizophrenia with atypical antipsychotics: a double-blind, randomised, placebo-controlled clinical trial;Berk;Hum Psychopharmacol,2009

5. Efficacy of mirtazapine add on therapy to haloperidol in the treatment of the negative symptoms of schizophrenia: a double-blind randomized placebo-controlled study;Berk;Int Clin Psychopharmacol,2001

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel pharmacotherapy targeting the positive symptoms of schizophrenia;Expert Opinion on Pharmacotherapy;2023-07-10

2. The Role of G Protein-Coupled Receptors (GPCRs) and Calcium Signaling in Schizophrenia. Focus on GPCRs Activated by Neurotransmitters and Chemokines;Cells;2021-05-17

3. Molecular targets of atypical antipsychotics: From mechanism of action to clinical differences;Pharmacology & Therapeutics;2018-12

4. Resistance is not futile: treatment-refractory schizophrenia – overview, evaluation and treatment;Expert Opinion on Pharmacotherapy;2018-11-08

5. Mirtazapine adjunct for people with schizophrenia;Cochrane Database of Systematic Reviews;2018-05-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3